Evidence Based Prescribing
Non-Medical Prescribing Update Training
Up to 35 delegates
The Course Aim
To enable participants to understand and take into account the evidence available in order to make safer prescribing decisions when prescribing for patients
By the end of the session participants will have an increased understanding of:
• Validity of research
• Clinical significance
• Application of evidence to practice
• “Am I bovered?” – The context of Evidence Based Prescribing
• “Playing with numbers”:
• Understanding risk; absolute or relative?
• Number needed to what exactly?
• “Is there a p-interval after coffee?” – confused about statistics and their significance?!
• “DOO or POO, that is the question!”
• “The appliance of science”
• Is it clinically significant if it’s statistically significant?
• “FOCC that!” – essential questions for the critical mind
Putting it all together:
Your chance to put it all into practice with some real life papers!
Prior to the course attendees will need to have (skim-) looked and obtained the following papers:
1. The PROactive study, The Lancet, 2005, 366, 1279 – 1289
2. The ASCOT-BPLA study, The Lancet, 2005, 366, 895 – 906
3. The DREAM study, The Lancet, 2006, 368, 1096 – 1105
These papers should be brought with you to use on the day.
Denise Rabbette registered as a Pharmacist in 1996. After completing a clinical diploma and moving into primary care and community services, she supported the Metropolitan Police to develop PGDs for use by nurses in custody suites before accepting a position as the Head of Medicines Management where she developed a support structure for Non-Medical Prescribers and embedded protected time in the workplace for reflective practice. In 2006 she emigrated to Egypt and worked as the healthcare correspondent for ‘Sharm Reality Magazine’ which was a lifestyle magazine intended for tourists and the ex-patriot population. On her return to the UK she took a position as a QoF assessor and PRIMIS facilitator and worked within Care Homes to reduce anticholinergic burden, reducing the use of antipsychotics and deprescribing. In 2015 she qualified as a prescriber and this led to the development of clinics for pain and atrial fibrillation management within GP practices. This opportunity then led to a position as an associate lecturer at the Medway School of Pharmacy. In 2016 she returned to a role as the Head of Medicines Optimisation taking responsibility for ensuring that the CCG commissions pathways and treatments that are evidence based and cost effective. In 2021 she left this role to increase her hours at Medway School of Pharmacy and works at a GP practice as the Lead Clinical Pharmacist.